I AM BIO

Biotechnology Innovation Organization
  • 0,0 (0)
  • SCIENCE DE LA VIE
  • DEUX FOIS PAR MOIS
I AM BIO

Powerful stories of biotechnology breakthroughs, the people they help, and the global problems they solve.

  1. 5 NOV.

    The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)

    The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking toxins. In this episode we talk with three experts about how this animal’s unique blue blood has become essential to modern medicine. We also talk about why horseshoe crab populations are dwindling, and what biotech is doing to address the shortfall.

    28 min

  2. 22 OCT.

    How Love Combined with Science Leads to Hope for Rare Disease

    There are over 7000 rare diseases identified in the U.S. alone. Many of these diseases affect children, leaving families desperate for answers. In this episode, we talk with one of those families and the biotech company offering them new hope. We also talk with an expert on policy that has jump-started R&D for rare diseases.

    27 min

  3. 8 OCT.

    How Will We Secure our Food Future?

    As the global population approaches 10 billion by 2050, the challenge of providing safe, nutritious food is growing more urgent. Climate change is further straining food systems, impacting water availability, crop yields, and livestock health. In this episode, two experts discuss innovative biotech solutions aimed at addressing these pressing issues, offering hope for a sustainable path forward in feeding the world.

    26 min

  4. 24 SEPT.

    Biotechnology is a National Security Asset

    Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security.

    27 min

  5. 10 SEPT.

    A Doctor Fights to Save His Own Life: The David Fajgenbaum Story.

    David Fajgenbaum was in his third year of medical school when he was diagnosed with a rare and life-threatening disease that began shutting down his organs, bringing him perilously close to death. Although he survived the initial episode, he faced four additional relapses, each pushing him to the brink of death. In this episode, we speak with David about his relentless journey to discover the treatment that ultimately put his disease into remission. We also explore how his personal battle inspired the creation of a groundbreaking approach to help others suffering from rare diseases.

    22 min

  6. 6 AOÛT

    What We Know About the Microbiome (REDUX)

    The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. Two companies, Bloom Science and Seres Therapeutics, are leveraging the microbiome to develop new therapeutics. The potential of the microbiome is vast, and further research and technological advancements will continue to unlock its benefits.

    27 min

  7. 24 JUIL.

    Is CRISPR the New Sickle Cell Savior? (REDUX)

    2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.

    25 min

  8. 7 MAI

    Listener takeover: Your Biotech Questions Answered

    YOU asked, and we answered. In this episode, we had our experts on standby to answer questions from you, our listeners. We discuss topics ranging from the safety of genetically modified foods (GMOs), to the new era of personalized medicine, feeding the world by 2050, and even what makes start-up companies attractive to investors.

    21 min
Tout afficher (128)

Hôtes et personnes invitées

À propos

Powerful stories of biotechnology breakthroughs, the people they help, and the global problems they solve.

Informations

  • Création
    Biotechnology Innovation Organization
  • Années d’activité
    2019 - 2024
  • Épisodes
    128
  • Classification
    Tous publics
  • Copyright
    © 2020 Biotechnology Innovation Organization
  • Site web de l’émission
    I AM BIO

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada